Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV randomized open-label study of levocetirizine versus ebastine on inflammatory markers in seasonal allergic rhinitis
2005-002231-27Phase 4Completed
- Sponsor
- Clínica del Dr. Lobatón
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in seasonal allergic rhinitis (SAR) comparing Levocetirizine with Ebastine (2 arms). Primary endpoint: Change in inflammatory markers in immune cell subsets. Started Dec 2005; status: completed.
02
Drugs
levocetirizineeribulin
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on 2005-002231-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002231-27.